Press releases
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition
- Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
- Bruker Corporation to Present at Upcoming Investor Conferences
- Bruker Announces Quarterly Dividend
- Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
- Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
- Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
- Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
- Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 86.50 |
---|---|
High | 86.50 |
Low | 86.50 |
Bid | 87.00 |
Offer | 87.50 |
Previous close | 85.00 |
Average volume | 76.56 |
---|---|
Shares outstanding | 137.67m |
Free float | 89.95m |
P/E (TTM) | 32.28 |
Market cap | 12.92bn USD |
EPS (TTM) | 2.91 USD |
Annual div (ADY) | 0.1851 EUR |
---|---|
Annual div yield (ADY) | 0.22% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of Mar 28 2024 07:01 BST.
More ▼